member of
- Institutional Animal Care and Use Committee (IACUC) Protocol review, animal research compliance review 2022 -
My areas of expertise are physiology, metabolism, molecular biology, and pharmacology, and my research interests lie in identifying proteins that promote inflammation and tissue dysfunction in metabolic and age-related pathologies. I use transgenic mouse models of diet-induced obesity and CRISPR/Cas9-edited cellular models of premature aging to identify disease-specific molecules that could be pharmacologically targeted to reverse metabolic dysfunction in aging, obesity, and Type 2 diabetes. I have published 20 original research papers in reputable journals (with ~2000 citations), secured extramural grants as Lead Principal Investigator (LPI), developed an independent research track, and submitted an Invention Disclosure to the Center for Technology Licensing New York (CTL-NY) describing a novel strategy to treat obesity and Type 2 Diabetes. Over the years, I have also actively mentored junior scientists and supported teaching activities in the Weill Cornell medical school and at Qatar University.